Article citationsMore>>

Stoch, S.A., Zajic, S., Stone, J.A., Miller, D.L., van Bortel, L., et al. (2013) Odanacatib, a Selective Cathepsin K Inhibitor to Treat Osteoporosis: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics—Results from Single Oral Dose Studies in Healthy Volunteers. British Journal of Clinical Pharmacology, 75, 1240-1254.
http://dx.doi.org/10.1111/j.1365-2125.2012.04471.x

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top